Raptor Pharmaceutical Inc. (RPTP) Announces Presentation at the International Pediatric Nephrology Association Meeting in Shanghai
8/29/2013 9:55:38 AM
NOVATO, Calif., Aug. 29, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that PROCYSBI (cysteamine bitartrate) will be featured in an upcoming presentation at the 16th Congress of the International Pediatric Nephrology Association being held in Shanghai, China. The presentation, titled "Extended treatment of patients with cystinosis and CKD with RP103 demonstrates efficacy and safety," will be given by Dr. Craig Langman of the Northwestern University Feinberg School of Medicine and is scheduled for 5:15 p.m. China Standard Time on Sunday, September 1, 2013 (Abstract O-42). Additional information about the conference can be found at www.ipna2013.org.
Help employers find you! Check out all the jobs and post your resume.
comments powered by